Representative before the EPO
Partner/Owner

Employment test 51 - 200 employees
Company dna carpmarls and ransford
operating since 1848
Headquarter in London and 2 offices
active in Legal Services and IP Consulting

We have observed 80 EP applications Hugh Goodfellow has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after December 07, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12706385

GENETICALLY MODIFIED PIGS FOR XENOTRANSPLANTATION OF VASCULARIZED XENOGRAFTS AND DERIVATIVES THEREOF

IPC classification:
C12N 5/10, A01K 67/027, C12N 15/85
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Status:
The patent has been granted
EP12707954

ADVANCED ACTIVE LIPOSOMAL LOADING OF POORLY WATER-SOLUBLE SUBSTANCES

IPC classification:
A61K 47/48, A61K 9/127
Agent:
Nederlandsch Octrooibureau N.V.
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP12785579

PROCESS FOR PURIFYING HEPARAN-N-SULFATASE

IPC classification:
A61K 38/47, C12N 9/24
Applicant:
Shire Human Genetic Therapies Inc
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Graham James Lock, Fry Heath & Spence LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12728007

LIPID NANOPARTICLE COMPOSITIONS AND METHODS FOR MRNA DELIVERY

IPC classification:
A61K 38/43, A61K 38/16, A61K 38/00, A61K 31/56, A61K 31/215, A61K 31/132, A61K 31/131
Applicant:
Shire Human Genetic Therapies Inc
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP12729758

MCAM ANTAGONISTS AND METHODS OF TREATMENT

IPC classification:
C07K 16/30
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP12818250

PENTRAXIN 3 ASSOCIATION WITH ASTHMA

IPC classification:
G01N 33/48
Applicant:
Janssen Biotech, Inc.
Applicant:
University of Michigan
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12710838

COMBINATION THERAPIES FOR HEMATOLOGIC MALIGNANCIES

IPC classification:
A61K 45/06, A61K 39/00, A61K 31/52, A61K 31/4439, A61K 31/4184, A61P 35/02, A61P 35/00
Applicant:
Gilead Calistoga LLC
Agent:
Georg Schnappauf, Zwicker Schnappauf & Partner Patentanwälte PartG mbB (ZSP)
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
APPLICATION WITHDRAWN
EP12714910

METHODS AND COMPOSITIONS FOR NORMALIZATION OF TUMOR VASCULATURE BY INHIBITION OF LOXL2

IPC classification:
A61K 31/7088, C07K 16/40
Applicant:
Gilead Biologics, Inc.
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12828354

PROCESS FOR RECOVERING SALT DURING A LIGNOCELLULOSIC CONVERSION PROCESS

IPC classification:
F22B 33/18, F22B 1/00, D21C 9/00, C12P 19/00, C12P 7/10, C05F 7/00, C05F 5/00, C02F 1/52, C02F 1/04
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
APPLICATION WITHDRAWN
EP12836507

COMPOUNDS FOR IMPROVED VIRAL TRANSDUCTION

IPC classification:
C12N 7/01, C12N 5/071, C12N 5/02
Applicant:
Bluebird Bio, Inc.
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Schiweck Weinzierl Koch Patentanwälte Partnerschaft mbB
Status:
The patent has been granted
EP12847487

ANTISENSE OLIGONUCLEOTIDE MODULATORS OF SEROTONIN RECEPTOR 2C AND USES THEREOF

IPC classification:
C12N 15/113, C07H 21/00
Applicant:
University of Kentucky
Applicant:
Shire Human Genetic Therapies Inc
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP12757516

METHODS AND USE OF BIFUNCTIONAL ENZYME-BUILDING CLAMP-SHAPED MOLECULES

IPC classification:
A61K 31/517, A61K 31/497, A01N 43/54, C07D 401/00, A61P 35/00
Applicant:
University of Pennsylvania
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Status:
The patent has been granted
EP11860324

NON-AQUEOUS HIGH CONCENTRATION REDUCED VISCOSITY SUSPENSION FORMULATIONS OF ANTIBODIES

IPC classification:
A61K 47/44, A61K 47/42, A61K 47/26, A61K 39/395, A61K 38/38, A61K 9/19, A61K 9/14, A61K 9/10, A61K 9/00
Applicant:
Janssen Biotech, Inc.
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP13197830

Fuel composition comprising a mixture of n-alkanes

IPC classification:
C12P 7/04, C12P 5/02, C12N 9/88, C12N 9/04, C12N 9/02, C12N 1/21, C10L 1/02, C07C 11/02
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP12860175

REACTIVE OXYGEN SPECIES-RESISTANT MICROORGANISMS

IPC classification:
C12P 7/06, C12N 15/52, C12N 15/31, C12N 1/21, C12N 1/20, C07H 21/04
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Patrick John Henry Campbell, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP14173039

Therapeutic compounds

IPC classification:
A61K 31/5375, A61K 31/435, A61K 31/426, A61K 31/4192, A61K 31/196, C07D 295/03, C07D 261/08, C07D 253/04, C07D 213/643, C07D 213/16, C07C 235/38, C07C 231/02, A61P 43/00, A61P 35/00, A61P 29/00, A61P 17/02, A61P 13/12, A61P 11/00, A61P 9/10
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Ström & Gulliksson AB
Status:
EXAMINATION IN PROGRESS
EP14163968

Pharmaceutical composition containing a heterocyclic modulator of ATP-binding cassette transporters

IPC classification:
A61K 31/443, C07D 405/12, A61P 11/00
Applicant:
Vertex Pharmaceuticals Incorporated
Agent:
Cohausz & Florack Partnerschaftsgesellschaft mbB
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Status:
PATENT GRANTED
EP12794811

MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS

IPC classification:
A61K 31/553, A61K 31/405, C07D 498/04, C07D 405/14, C07D 405/12, A61P 35/00, A61P 27/00, A61P 25/00, A61P 11/00, A61P 3/00, A61P 1/00
Applicant:
Vertex Pharmaceuticals Incorporated
Agent:
Cohausz & Florack Partnerschaftsgesellschaft mbB
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Status:
PATENT GRANTED
EP14168373

Modulators of CFTR

IPC classification:
A61K 31/444, C07D 405/14, C07D 401/04, A61P 37/00, A61P 11/00
Applicant:
Vertex Pharmaceuticals Incorporated
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP12787303

USE OF (N- [2, 4 -BIS (1, 1 -DIMETHYLETHYL) - 5 - HYDROXYPHENYL]- 1, 4 - DIHYDRO - 4 - OXOQUINOLINE - 3 - CARBOXAMIDE) FOR TREATING CFTR MEDIATED DISEASES

IPC classification:
A61K 31/47
Applicant:
Vertex Pharmaceuticals Incorporated
Agent:
Cohausz & Florack Partnerschaftsgesellschaft mbB
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Status:
APPLICATION WITHDRAWN
EP13741481

GENERATION OF PHOTORECEPTORS FROM HUMAN RETINAL PROGENITOR CELLS USING POLYCAPROLACTONE SUBSTRATES

IPC classification:
A61F 2/00, A01N 63/00, C12N 5/00
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13703243

FORMULATIONS OF 3-(6-(1-(2.2-DIFLUOROBENZO[D][1,3]DIOXOL-5-YL) CYCLOPROPANECARBOXAMIDO)-3-METHYLPYRIDIN-2-YL)BENZOIC ACID

IPC classification:
A61K 31/443, A61K 9/28, A61K 9/20, A61K 9/16, C07D 405/14, C07D 405/12, C07D 213/75
Applicant:
Vertex Pharmaceuticals Incorporated
Agent:
Cohausz & Florack Partnerschaftsgesellschaft mbB
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP12752152

ASSAYS FOR ANTIBODIES WHICH BIND TO THERAPEUTIC AGENTS

IPC classification:
G01N 33/68, G01N 33/543, C12N 11/00
Applicant:
Shire Human Genetic Therapies Inc
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Graham James Lock, Fry Heath & Spence LLP
Status:
GRANT OF PATENT INTENDED
EP13708625

PHARMACEUTICAL COMPOSITION AND ADMINISTRATION THEREOF

IPC classification:
A61K 47/38, A61K 47/32, A61K 47/26, A61K 47/02, A61K 31/47, A61K 9/16
Applicant:
Vertex Pharmaceuticals Incorporated
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP13755552

VARIANTS OF PROTHYMOSIN ALPHA AND METHODS OF USING SAME

IPC classification:
A61K 38/00
Agent:
Fabrizio Minoja, Bianchetti Bracco Minoja Srl
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP13703505

TFPI INHIBITORS AND METHODS OF USE

IPC classification:
A61K 38/10, C07K 7/08, A61P 7/02
Applicant:
Baxalta Incorporated
Applicant:
Baxalta GmbH
Applicant:
Baxter Healthcare SA
Applicant:
Baxter International Inc
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Potter Clarkson LLP
Status:
GRANT OF PATENT INTENDED
EP13778780

HUMAN ANTIBODIES AND SPECIFIC BINDING SEQUENCES THEREOF FOR USE IN STROKE AND ISCHEMIA OR ISCHEMIC CONDITIONS

IPC classification:
A61K 39/395
Applicant:
Mayo Foundation for Medical Education and Research
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Andrew John Teuten, Sagittarius IP
Status:
The patent has been granted
EP13788302

HETEROMULTIMER CONSTRUCTS OF IMMUNOGLOBULIN HEAVY CHAINS WITH MUTATIONS IN THE FC DOMAIN

IPC classification:
A61K 39/395, C07K 16/46, C07K 16/30, C07K 16/28, C07K 16/24, C07K 16/12, A61P 37/02, A61P 35/00
Applicant:
Zymeworks Inc
Agent:
Glyn John Truscott, Elkington and Fife LLP
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Hendrik Wichmann, Wuesthoff & Wuesthoff Patentanwälte PartG mbB
Status:
GRANT OF PATENT INTENDED
EP13819634

ANTI-SIGLEC-15 ANTIBODIES

IPC classification:
A61K 39/395, C12N 15/85, C12N 15/13, C12N 5/10, C07K 16/28, A61P 19/08
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Agent:
William Gerrit Arends, Marks & Clerk
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Rebecca Katherine Gardner, Dehns Ltd
Status:
GRANT OF PATENT INTENDED
EP13829280

METHODS AND SYSTEMS FOR SCREENING COMPOSITIONS COMPRISING NON-ANTICOAGULANT SULFATED POLYSACCHARIDES

IPC classification:
G01N 33/86, G01N 33/50, G01N 33/48
Applicant:
Baxalta Incorporated
Applicant:
Baxalta GmbH
Applicant:
Baxter Healthcare SA
Applicant:
Baxter International Inc
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Multiple attorneys, Stevens Hewlett & Perkins
Status:
EXAMINATION IN PROGRESS
EP12745098

SOLAR THERMAL ENERGY CAPTURE SYSTEM WITH OVERHEATING PROTECTION AND COLD TEMPERATURE BYPASS

IPC classification:
F24D 19/08, H02S 40/44, F24D 19/10, F24D 17/00, F24J 2/34, F24J 2/46, F24J 2/40
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP13812072

APPARATUS AND METHOD FOR BLOOD COLLECTION

IPC classification:
A61B 5/15
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP13855452

DIGITAL ANALYSIS OF MOLECULAR ANALYTES USING SINGLE MOLECULE DETECTION

IPC classification:
G06F 19/00
Agent:
Glyn John Truscott, Elkington and Fife LLP
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP14740167

EVALUATION, ASSAYS AND TREATMENT OF PKAL-MEDIATED DISORDERS

IPC classification:
G01N 33/50, G01N 33/48, C12Q 1/56
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Potter Clarkson LLP
Status:
GRANT OF PATENT INTENDED
EP14740444

EVALUATION AND TREATMENT OF BRADYKININ-MEDIATED DISORDERS

IPC classification:
C07K 16/40
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Potter Clarkson LLP
Status:
The patent has been granted
EP14769180

METHODS OF CELL CULTURE

IPC classification:
A61K 39/395
Applicant:
Momenta Pharmaceuticals Inc
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14776142

METHODS OF CELL CULTURE

IPC classification:
C12N 5/02, C12N 5/00, C12P 1/00
Applicant:
Momenta Pharmaceuticals Inc
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14775649

METHODS OF CELL CULTURE

IPC classification:
C12N 5/07, C12N 5/00, C12P 21/04
Applicant:
Momenta Pharmaceuticals Inc
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14718260

METHOD OF CHARACTERIZING LYSOSOMAL ENZYMES

IPC classification:
C12N 9/24, C07K 1/26
Applicant:
Shire Human Genetic Therapies Inc
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP14721659

CD14+ CELL COMPOSITIONS AND METHODS OF USING SAME

IPC classification:
C12N 5/0775, A61P 9/10, C12N 5/071, A61K 35/28, C12N 5/0786
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Cooley (UK) LLP
Status:
EXAMINATION REQUESTED
EP15177547

CANCER THERAPIES AND PHARMACEUTICAL COMPOSITIONS USED THEREIN

IPC classification:
C07K 16/28, A61K 31/575, A61P 35/00, A61K 39/395, A61K 31/337, A61K 31/475, A61K 31/573, A61K 31/4745, A61K 31/70, A61K 31/7088, A61K 45/06
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13167785

Modulators of ATP-binding cassette transporters

IPC classification:
C07D 471/04, A61P 31/00, A61K 31/404, C07D 405/14, C07D 405/12
Applicant:
Vertex Pharmaceuticals Incorporated
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Agent:
Cohausz & Florack Partnerschaftsgesellschaft mbB
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14803492

PHARMACEUTICAL COMPOSITIONS COMPRISING PYROPHOSPHATE

IPC classification:
C01B 25/42, A61K 47/42, A61K 39/395
Applicant:
Momenta Pharmaceuticals Inc
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP14845354

METHODS AND COMPOSITIONS FOR GENERATION OF BINDING AGENTS AGAINST CELL SURFACE ANTIGENS

IPC classification:
C12Q 1/68, G01N 33/53
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Jörk Zwicker, Zwicker Schnappauf & Partner Patentanwälte PartG mbB (ZSP)
Status:
GRANT OF PATENT INTENDED
EP14810067

CELL SEEDING DEVICE AND METHOD

IPC classification:
C12M 1/12
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Cooley (UK) LLP
Status:
EXAMINATION REQUESTED
EP15709067

PEPTIDES AND METHODS OF USE

IPC classification:
A61K 38/00, C07K 7/08, C07K 14/745
Applicant:
Baxalta GmbH
Applicant:
Baxalta Incorporated
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Potter Clarkson LLP
Status:
EXAMINATION REQUESTED
EP15769534

COMPOSITIONS AND METHODS FOR TREATMENT OF DIABETIC MACULAR EDEMA

IPC classification:
A61P 27/02, A61K 39/395, C07K 16/40
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP15721094

METHODS FOR ISOLATING, CULTURING, AND GENETICALLY ENGINEERING IMMUNE CELL POPULATIONS FOR ADOPTIVE THERAPY

IPC classification:
C12N 5/0783, C12N 5/0781
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Frances Salisbury, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15726501

SUBSTRATE-MEDIATED REACTORS FOR BIOASSAYS

IPC classification:
G01N 33/543, G01N 33/538
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP16195158

TFPI INHIBITORS AND METHODS OF USE

IPC classification:
C07K 14/81, A61K 38/18
Applicant:
Baxalta Incorporated
Applicant:
Baxalta GmbH
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Potter Clarkson LLP
Status:
EXAMINATION REQUESTED
EP15831523

MODIFIED IL-2 VARIANTS THAT SELECTIVELY ACTIVATE REGULATORY T CELLS FOR THE TREATMENT OF AUTOIMMUNE DISEASES

IPC classification:
C07K 17/08, C07K 14/55, A61K 38/20
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP16196664

METHOD TO PREDICT AND PREVENT OXYGEN-INDUCED INFLAMMATORY TISSUE INJURY

IPC classification:
A61K 45/06, A61P 43/00, A61K 33/00, A61K 31/00, A61K 31/7076
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
Request for examination was made
EP15759685

IODOPHOR COMPOSITION WITH IMPROVED STABILITY IN THE PRESENCE OF ORGANIC MATERIAL

IPC classification:
A23C 7/00, A61K 8/22, A61K 8/20, A61K 9/00, A61K 33/18, A01P 1/00, A01N 25/22, A01N 59/24, A01N 59/12
Applicant:
National University of Ireland, Galway (National University of Ireland Galway)
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Tomkins & Co
Status:
Request for examination was made
EP17150192

CELLS ON A SUPPORT MATRIX FOR TISSUE REPAIR

IPC classification:
C12N 5/00, A61K 35/12, A61L 27/38
Applicant:
Verigen AG
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Cooley (UK) LLP
Status:
The application has been published
EP15816318

METHODS AND COMPOSITIONS FOR ADOPTIVE CELL THERAPY

IPC classification:
C07K 16/28, C07K 14/725, C07K 14/705
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
Request for examination was made
EP15823264

ENZYMATIC ACTIVITY ASSAYS FOR GLUCOCEREBROSIDASE

IPC classification:
C12Q 1/34
Applicant:
Shire Human Genetic Therapies Inc
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP15823270

ENZYMATIC ACTIVITY ASSAYS FOR I2S

IPC classification:
C12Q 1/34
Applicant:
Shire Human Genetic Therapies Inc
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP16703392

MODIFIED HEPATITIS POST-TRANSCRIPTIONAL REGULATORY ELEMENTS

IPC classification:
C12N 15/867, C12N 15/85
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
Request for examination was made
EP16742568

ENGINEERED CELLS FOR ADOPTIVE CELL THERAPY

IPC classification:
C12N 5/0783
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
Request for examination was made
EP16854189

DIAGNOSIS AND TREATMENT OF PARKINSON'S DISEASE BASED ON IDENTIFICATION AND AMELIORATION OF LIVER DYSFUNCTION

IPC classification:
C12N 5/074, C12N 5/071, A61K 35/545, A61K 35/407
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP16795177

MODIFICATION OF RNA-RELATED ENZYMES FOR ENHANCED PRODUCTION

IPC classification:
C12N 15/62, C12N 9/12
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP16801293

METHODS FOR CULTURING CELLS AND KITS AND APPARATUS FOR SAME

IPC classification:
G01N 1/30, C12N 5/0783
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP16791171

IMMUNOASSAY TO DETECT CLEAVED HIGH MOLECULAR WEIGHT KININOGEN

IPC classification:
G01N 33/86, G01N 33/68
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP16810017

METHODS FOR CULTURING CELLS AND KITS AND APPARATUS FOR SAME

IPC classification:
C12N 5/00, C12N 5/0775, G01N 33/569
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP16861006

COMPOSITIONS AND METHODS FOR TUMOR TRANSDUCTION

IPC classification:
C12P 21/08, C07K 16/28, C07K 16/18, A61P 35/00, A61K 45/00, A61K 39/395
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP16861008

COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER

IPC classification:
C07K 19/00, C07K 16/28, C07K 14/705
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP16810123

CHIMERIC RECEPTORS CONTAINING TRAF-INDUCING DOMAINS AND RELATED COMPOSITIONS AND METHODS

IPC classification:
C07K 14/705, C07K 14/00, A61K 35/17, A61K 39/00
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP16862739

CELL CYCLE BLOCK IMPROVES EFFICIENCY IN GENERATING INDUCED PLURIPOTENT STEM CELLS

IPC classification:
C12N 5/071, A61K 35/35, A61K 35/12, A61K 35/545
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP16865056

PLATELET BIOMARKERS AND DIAGNOSTIC METHODS FOR VASCULAR DISEASES

IPC classification:
G01N 33/53, G01N 33/50, G01N 1/40, C12N 5/078, C07K 16/18, C07K 14/47, A61P 7/02
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP16856265

METHODS AND COMPOSITIONS FOR THE TREATMENT OF EPIDERMOLYSIS BULLOSA

IPC classification:
A61P 17/02, A61K 31/415, A61K 38/12, A61K 38/08
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP16810158

RECOMBINANT HUMAN C1 ESTERASE INHIBITOR AND USES THEREOF

IPC classification:
C07K 14/81, A61K 38/57
Applicant:
Shire Human Genetic Therapies Inc
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP16829013

MODIFIED CHIMERIC RECEPTORS AND RELATED COMPOSITIONS AND METHODS

IPC classification:
C07K 14/705
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP16802111

TRANSDUCTION BUFFER

IPC classification:
A61K 31/205, C12N 15/87, A61K 47/02, A61K 47/26, A61K 47/18, A61K 47/10
Applicant:
Royal Netherlands Academy of Arts and Sciences (Koninklijke Nederlandse Akademie van Wetenschappen (KNAW))
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP16822844

PLASMA KALLIKREIN INHIBITORS AND USES THEREOF FOR TREATING HEREDITARY ANGIOEDEMA ATTACK

IPC classification:
A61K 39/395, A61K 39/00, C07K 16/40
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP18154983

ANTI-PSGL-1 ANTIBODIES AND METHODS OF IDENTIFICATION AND USE

IPC classification:
C07K 16/28, C12P 21/08
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
The application has been published
EP18170703

COMPOSITIONS FOR TREATING STOMACHAL AND OESOPHAGEAL CANCER CELLS

IPC classification:
G01N 33/574, C12N 15/113, C12Q 1/6886, C07K 16/30, A61K 31/7048, A61K 51/10, A61K 9/127, A61K 31/7034, C07H 21/04, C12P 19/34, C12Q 1/68
Applicant:
Thomas Jefferson University
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
The application has been published
EP16825947

PEPTIDE QUANTITATION ASSAY FOR DIFFERENTIATING FULL-LENGTH HIGH MOLECULAR WEIGHT KININOGEN (HMWK) AND CLEAVED HMWK

IPC classification:
G01N 33/68, C07K 14/81
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP16822558

METHODS AND COMPOSITIONS RELATED TO TOXICITY ASSOCIATED WITH CELL THERAPY

IPC classification:
G01N 33/68
Applicant:
Fred Hutchinson Cancer Research Center
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP16876662

METHODS OF TREATING EXACERBATED INFLAMMATORY RESPONSE WITH TOPOISOMERASE l INHIBITORS

IPC classification:
A61P 35/00, A61K 38/06
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made
EP16826889

2H-CHROMENO[2,3-D]PYRIMIDINE-2,4(3H)-DIONES AS NF-KB INHIBITORS

IPC classification:
A61P 35/00, A61P 37/00, A61P 29/00, A61K 31/519, C07D 495/04, C07D 491/052
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
Request for examination was made

Please Sign in to use this feature